Trial-level prediction of long-term outcome based on pathologic complete response (pCR) after neoadjuvant chemotherapy for early-stage breast cancer (EBC)

Early Stage ◽

Complete Response ◽

Term Outcome ◽

A model for trial level prediction of long term outcome based on pathological complete response (pCR) after neoadjuvant chemotherapy for early-stage breast cancer (EBC).

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.1031 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 1031-1031

Author(s):

Valentina Nekljudova ◽

Sibylle Loibl ◽

Gunter Von Minckwitz ◽

Stefan Gluck ◽

Richard Crane ◽

...

Keyword(s):

Breast Cancer ◽

Pathological Complete Response ◽

Early Stage ◽

Complete Response ◽

Term Outcome ◽

Abstract PS13-08: Predictors and long-term outcome of pathologic complete response in patients receiving neoadjuvant chemotherapy for breast cancer - an NCDB analysis

10.1158/1538-7445.sabcs20-ps13-08 ◽

2021 ◽

Author(s):

Lauren Mikesell Panebianco ◽

Prashanth Ashok Kumar ◽

Shreya Sinha ◽

Dongliang Wang ◽

Danning Huang ◽

...

Keyword(s):

Breast Cancer ◽

Complete Response ◽

Term Outcome ◽

Correlation of various pathologic complete response (pCR) definitions with long-term outcome and the prognostic value of pCR in various breast cancer subtypes: Results from the German neoadjuvant meta-analysis.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.1028 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 1028-1028 ◽

Cited By ~ 20

Author(s):

G. Von Minckwitz ◽

M. Kaufmann ◽

S. Kuemmel ◽

P. A. Fasching ◽

W. Eiermann ◽

...

Keyword(s):

Breast Cancer ◽

Prognostic Value ◽

Meta Analysis ◽

Complete Response ◽

Breast Cancer Subtypes ◽

Term Outcome ◽

Long Term Outcome ◽

Cancer Subtypes

Abstract P5-20-05: Impact of type of (neo)adjuvant systemic therapy (AdjTx) and total exposure to trastuzumab (TET) on long-term outcome of HER2-positive (HER2+) early stage breast cancer (ESBrCa)

10.1158/1538-7445.sabcs17-p5-20-05 ◽

2018 ◽

Author(s):

G Gullo ◽

N Walsh ◽

D Fennelly ◽

J Walshe ◽

K O'Mahony ◽

...

Keyword(s):

Breast Cancer ◽

Systemic Therapy ◽

Early Stage ◽

Adjuvant Systemic Therapy ◽

Her2 Positive ◽

Term Outcome ◽

Long Term Outcome ◽

Total Exposure

Abstract P2-16-06: In-breast pathologic complete response (pCR) following neoadjuvant chemotherapy predicts nodal pCR in early stage breast cancer

10.1158/1538-7445.sabcs19-p2-16-06 ◽

2020 ◽

Author(s):

Achraf Shamseddine ◽

Jessica Flynn ◽

Zhigang Zhang ◽

Monica Morrow ◽

Boris Mueller ◽

...

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Complete Response ◽

Early Stage Breast Cancer

Long-term outcome with interstitial brachytherapy in the management of patients with early-stage breast cancer treated with breast-conserving therapy

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(96)00606-2 ◽

1997 ◽

Vol 37 (4) ◽

pp. 845-852 ◽

Cited By ~ 36

Author(s):

Frank A. Vicini ◽

Eric M. Horwitz ◽

Mario D. Lacerna ◽

Carl F. Dmuchowski ◽

Douglas M. Brown ◽

...

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Breast Conserving Therapy ◽

Interstitial Brachytherapy ◽

Term Outcome ◽

Impact of pathologic complete response on survival after neoadjuvant chemotherapy in early-stage breast cancer: a population-based analysis

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-019-03083-y ◽

2019 ◽

Vol 146 (2) ◽

pp. 529-536 ◽

Cited By ~ 3

Author(s):

Nathalie LeVasseur ◽

J. Sun ◽

L. Gondara ◽

R. Diocee ◽

C. Speers ◽

...

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Complete Response ◽

Population Based ◽

Early Stage Breast Cancer

High Pathologic Complete Response in Her2-Positive, Early-Stage Breast Cancer to a Novel Nonanthracycline Neoadjuvant Chemotherapy

Clinical Breast Cancer ◽

10.1016/j.clbc.2014.06.004 ◽

2015 ◽

Vol 15 (1) ◽

pp. 31-36 ◽

Cited By ~ 10

Author(s):

Amelia B. Zelnak ◽

Petros Nikolinakos ◽

Jayanthi Srinivasiah ◽

William Jonas ◽

Andrew Pippas ◽

...

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Complete Response ◽

Her2 Positive

Abstract P5-14-12: Long-term outcome of HER2-normal early stage breast cancer (ESBC) patients (Pts) treated with docetaxel-cyclophosphamide (TC) chemotherapy (CTx): Mature results of a single-institution experience

10.1158/1538-7445.sabcs16-p5-14-12 ◽

2017 ◽

Author(s):

A Losurdo ◽

G Gullo ◽

C Buckley ◽

C Lowry ◽

J Ballot ◽

...

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Single Institution ◽

Term Outcome ◽

Long-term outcome after breast conservation (BCT) for early stage breast cancer in a community setting

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2004.07.243 ◽

2004 ◽

Vol 60 (1) ◽

pp. S383

Author(s):

S.A. McCloskey ◽

L.E. Botnick ◽

C.M. Rose ◽

A.W. Malcolm ◽

M. Ozahan ◽

...

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Breast Conservation ◽

Community Setting ◽

Term Outcome ◽